483
Naoto Ueno, M.D.FDA 483 - Naoto Ueno, M.D. - July 06, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Naoto Ueno, M.D., a clinical investigator in Houston, TX, revealed a significant procedural issue in a clinical study. The firm failed to conduct an investigation in accordance with the signed statement of investigator and investigational plan. Specifically, concomitant medications received by subjects during the study period were not reported to the sponsor.
Open in Dashboard
ID · d2cdd134-5914-46eb-b64d-90e6536f6c5d